Indocyanine Green Retention Test as a Predictor of Postoperative Complications in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma

References

• Zhou J, Sun H, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition). Liver Cancer. 2018;7:235–260. doi:10.1159/000488035
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
   PubMed Web of Science ®Google Scholar
• Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–724. doi:10.1016/j.surg.2010.10.001
   PubMed Web of Science ®Google Scholar
• Balzan S, Belghiti J, Farges O, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242(6):824–8, discussion 828–9. doi:10.1097/01.sla.0000189131.90876.9e
   PubMed Web of Science ®Google Scholar
• Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240(4):698–708; discussion 708–10. doi:10.1097/01.sla.0000141195.66155.0c
   Web of Science ®Google Scholar
• Wei AC, Tung-Ping PR, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg. 2003;90(1):33–41. doi:10.1002/bjs.4018
   PubMed Web of Science ®Google Scholar
• Donadon M, Costa G, Cimino M, et al. Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score. World J Surg. 2015;39(1):237–243. doi:10.1007/s00268-014-2786-6
   PubMed Web of Science ®Google Scholar
• Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(1):S100–S107. doi:10.1016/j.jhep.2004.11.015
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach- the ALBI grade. J Clin Oncol. 2015;33(6):550–558. doi:10.1200/JCO.2014.57.9151
   PubMed Web of Science ®Google Scholar
• Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–96. doi:10.1053/gast.2003.50016
   PubMed Web of Science ®Google Scholar
• Wang YY, Zhong JH, Su ZY, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg. 2016;103(6):725–734. doi:10.1002/bjs.10095
   PubMed Web of Science ®Google Scholar
• Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 1960;39:592–600. doi:10.1172/JCI104072
   PubMed Web of Science ®Google Scholar
• Burczynski FJ, Pushka KL, Sitar DS, Greenway CV. Hepatic plasma flow: accuracy of estimation from bolus injections of indocyanine green. Am J Physiol. 1987;252(5 Pt 2):H953–62. doi:10.1152/ajpheart.1987.252.5.H953
   PubMed Web of Science ®Google Scholar
• Kokudo T, Hasegawa K, Kokudo N. Assessment of preoperative liver function based on indocyanine green clearance. Hepatology. 2017;66(2):675–676. doi:10.1002/hep.29232
   PubMed Web of Science ®Google Scholar
• Yamada A, Hara T, Li F, et al. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology. 2011;260(3):727–733. doi:10.1148/radiol.11100586
   PubMed Web of Science ®Google Scholar
• Ibis C, Albayrak D, Sahiner T, Soytas Y, Gurtekin B, Sivrikoz N. Value of preoperative indocyanine green clearance test for predicting post-hepatectomy liver failure in noncirrhotic patients. Med Sci Monit. 2017;23:4973–4980. doi:10.12659/msm.907306
   PubMed Web of Science ®Google Scholar
• Schwarz C, Plass I, Fitschek F, et al. The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Sci Rep. 2019;9(1):8421. doi:10.1038/s41598-019-44815-x
   PubMed Web of Science ®Google Scholar
• Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology. 2015;61(2):526–536. doi:10.1002/hep.27431
   PubMed Web of Science ®Google Scholar
• Wang YY, Xiang BD, Ma L, et al. Development and validation of a nomogram to preoperatively estimate post-hepatectomy liver dysfunction risk and long-term survival in patients with hepatocellular carcinoma. Ann Surg. 2020;274(6):e1209–e1217. doi:10.1097/SLA.0000000000003803
   Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae
   PubMed Web of Science ®Google Scholar
• Pol B, Campan P, Hardwigsen J, Botti G, Pons J, Le TYP. Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg. 1999;165(5):446–453. doi:10.1080/110241599750006686
   PubMedGoogle Scholar
• Mai RY, Ye JZ, Long ZR, et al. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res. 2019;11:1401–1414. doi:10.2147/CMAR.S186114
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989X06295361
   PubMed Web of Science ®Google Scholar
• Gurusamy KS, Li J, Sharma D, Davidson BR, Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev. 2009;(4):CD008085. doi:10.1002/14651858.CD008085
   PubMed Web of Science ®Google Scholar